MabCure Launches Clinical Trial To Diagnose Ovarian Cancer

Links shared publicly online about this topic.

  • 1,472
    total visits

MabCure Launches Clinical Trial To Diagnose Ovarian Cancer

medicalnewstoday.com —

Mabcure, n.v. (mabcure) a wholly-owned subsidiary of mabcure inc. (otcbb: mbci) , a biotech company that has developed a series of highly specific monoclonal antibodies (mabs) to combat various

View full resource at medicalnewstoday.com

Tags: Cancer, Ovarian Cancer, Clinical Trial, Biotech, Women's Health

  • Share

Most Recently Shared on January 8, 2010 at 9:37 am By:

medical_tweets medical_tweets

MabCure Launches Clinical Trial To Diagnose Ovarian Cancer MabCure, N.V. ("MabCure") a wholly-owned subsidiary of Mab.. http://bit.ly/7CArhQ

2 years ago...

Reply

Retweet

Favorite

Also Shared By:

MNT Cancer News MNT Cancer News

MNT Clinical Trials MNT Clinical Trials

Advertisement